DrugDashboards

Market view

dextromethorphan hbr/guaifenesin · Tablet

1 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for dextromethorphan hbr/guaifenesin, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Mucus Relief DmAug 7, 2026
    Product update
    marketing status: OTC MONOGRAPH FINAL → OTC MONOGRAPH DRUG · +1 more

Same drug class

Other molecules FDA puts in Uncompetitive N-methyl-D-aspartate Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Dextromethorphan hbr/guaifenesin in shortage right now?
No. FDA does not currently list Dextromethorphan hbr/guaifenesin in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Dextromethorphan hbr/guaifenesin?
1 company has marketed Dextromethorphan hbr/guaifenesin in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.